Grufity logo
Grufity logo
CING

CING - Cingulate Inc. Stock Price, Fair Value and News

$4.77-0.16 (-3.25%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

Price Targets

CING Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CING Price Action

Last 7 days

9.3%

Last 30 days

8.3%

Last 90 days

-57.5%

Trailing 12 Months

17.9%

CING RSI Chart

CING Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CING Valuation

Market Cap

56.8M

Price/Earnings (Trailing)

-2.04

EV/EBITDA

-1.13

Price/Free Cashflow

-2.87

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

CING Fundamentals

CING Revenue

CING Earnings

Earnings (TTM)

-27.9M

Earnings Growth (Yr)

-141.7%

Earnings Growth (Qtr)

-48.45%

CING Profitability

Return on Equity

-147.94%

Return on Assets

-90.43%

Free Cashflow Yield

-34.81%

CING Investor Care

Shares Dilution (1Y)

211.23%

Diluted EPS (TTM)

-4.29

CING Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2025----
2024----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Cingulate Inc.

CING
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders intended for children, adolescents, and adults. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
 CEO
 WEBSITEcingulate.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES15

Cingulate Inc. Frequently Asked Questions

CING is the stock ticker symbol of Cingulate Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Cingulate Inc. is 58.71 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.